FRA:ILU - Deutsche Boerse Ag - US4523271090 - Common Stock - Currency: EUR
FRA:ILU (3/7/2025, 7:00:00 PM)
77.26
-2.3 (-2.89%)
The current stock price of ILU.DE is 77.26 EUR. In the past month the price decreased by -28.87%. In the past year, price decreased by -38.08%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.07 | 182.78B | ||
DAP.DE | DANAHER CORP | 28.32 | 139.67B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 55.77 | 19.00B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 46.36 | 17.15B | ||
SRT.DE | SARTORIUS AG | 37.17 | 13.75B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 28.63 | 9.95B | ||
ERF.PA | EUROFINS SCIENTIFIC | 28.53 | 9.91B | ||
QIA.DE | QIAGEN N.V. | 18.07 | 7.89B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 25.09 | 3.74B | ||
GXI.DE | GERRESHEIMER AG | 25.2 | 2.77B | ||
EVT.DE | EVOTEC SE | N/A | 2.34B |
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA US
Employees: 10615
Company Website: https://www.illumina.com
Investor Relations: https://investor.illumina.com
Phone: 18582024500
The current stock price of ILU.DE is 77.26 EUR. The price decreased by -2.89% in the last trading session.
The exchange symbol of ILLUMINA INC is ILU and it is listed on the Deutsche Boerse Ag exchange.
ILU.DE stock is listed on the Deutsche Boerse Ag exchange.
31 analysts have analysed ILU.DE and the average price target is 140.02 EUR. This implies a price increase of 81.23% is expected in the next year compared to the current price of 77.26. Check the ILLUMINA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ILLUMINA INC (ILU.DE) has a market capitalization of 12.24B EUR. This makes ILU.DE a Large Cap stock.
ILLUMINA INC (ILU.DE) currently has 10615 employees.
ILLUMINA INC (ILU.DE) has a support level at 77.25 and a resistance level at 132.97. Check the full technical report for a detailed analysis of ILU.DE support and resistance levels.
The Revenue of ILLUMINA INC (ILU.DE) is expected to grow by 0.64% in the next year. Check the estimates tab for more information on the ILU.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ILU.DE does not pay a dividend.
ILLUMINA INC (ILU.DE) will report earnings on 2025-04-30, after the market close.
The PE ratio for ILLUMINA INC (ILU.DE) is 34.19. This is based on the reported non-GAAP earnings per share of 2.26 and the current share price of 77.26 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ILU.DE.
ChartMill assigns a fundamental rating of 4 / 10 to ILU.DE. Both the profitability and the financial health of ILU.DE get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months ILU.DE reported a non-GAAP Earnings per Share(EPS) of 2.26. The EPS increased by 181.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -19.39% | ||
ROE | -51.5% | ||
Debt/Equity | 0.63 |
ChartMill assigns a Buy % Consensus number of 74% to ILU.DE. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 88.3% and a revenue growth 0.64% for ILU.DE